BioSyntech, Inc. develops biotherapeutic thermogels designed for tissue repair and delivery of therapeutic agents. The company develops products for cartilage repair, chronic wound healing and heel pain relief. It also develops tissue repair products for bone reconstruction and intervertebral disc treatment. The company is also engaged in the development of advanced injectable biomaterials for the delivery of cells, genes and biotherapeutic agents. It also develops instrumentation products. BioSyntech was founded December 14, 1994 and is headquartered in Laval, Canada.